We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Otsuka Pharmaceutical Buys Mass. Biotech For $430M In Cash

Law360 (July 11, 2018, 6:58 PM EDT) -- Japan’s Otsuka Pharmaceutical Co. Ltd. has agreed to buy private equity-backed, Massachusetts-based clinical stage biotechnology company Visterra Inc. for $430 million in cash in a deal already approved by both their...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.